Genetic variation in the inhibin pathway and risk of testicular germ cell tumors

Cancer Research

Volumn 68, Issue 8, 2008, Pages 3043-3048

  Purdue, Mark P ^a   Graubard, Barry I ^a   Chanock, Stephen J ^a   Rubertone, Mark V ^b   Erickson, Ralph L ^c   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b US Army Center for Health Promotion and Preventive Medicine   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERM CELL TUMOR; HUMAN; INHA GENE; INHBA GENE; INHBB GENE; INHBC GENE; INHBE GENE; KNOCKOUT MOUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD4 GENE; TERATOCARCINOMA; TERATOMA; TESTIS CANCER;

ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; INHIBINS; MALE; MICE; MILITARY PERSONNEL; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TESTICULAR NEOPLASMS; UNITED STATES; VARIATION (GENETICS);

EID: 42349092879     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5852     Document Type: Article

References (36)

1. McGlynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Invest 2001;19:842-53.
2. Rajpert-De ME, Skakkebaek NE. The possible role of sex hormones in the development of testicular cancer. Eur Urol 1993;23:54-9.
3. United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group. BMJ 1994;308:1393-9.
4. O'Connor AE, de Kretser DM. Inhibins in normal male physiology. Semin Reprod Med 2004;22:177-85.
5. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. α-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992;360:313-9.
6. McGlynn KA, Sakoda LC, Rubertone MV, et al. Body size, dairy consumption, puberty and risk of testicular germ cell tumors. Am J Epidemiol 2007;165:355-63.
7. Purdue MP, Sakoda LC, Graubard BI, et al. A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 2007;16:77-83.
8. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 2002;92:1900-4.
9. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20.
10. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
11. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005;28:261-72.
12. A haplotype map of the human genome. Nature 2005;437:1299-320.
13. Zeggini E, Rayner W, Morris AP, et al. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat Genet 2005;37:1320-2.
14. Shelling AN, Burton KA, Chand AL, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000;15:2644-9.
15. Marozzi A, Porta C, Vegetti W, et al. Mutation analysis of the inhibin a gene in a cohort of Italian women affected by ovarian failure. Hum Reprod 2002;17:1741-5.
16. Dixit H, Deendayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004;19:1760-4.
17. Chand AL, Robertson DM, Shelling AN, Harrison CA. Mutational analysis of βglycan/TGF-βRIII in premature ovarian failure. Fertil Steril 2007;87:210-2.
18. Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 2000;6:637-41.
19. Chen JM, Ferec C, Cooper DN. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 2006;120:1-21.
20. Mellor SL, Richards MG, Pedersen JS, Robertson DM, Risbridger GP. Loss of the expression and localization of inhibin α-subunit in high grade prostate cancer. J Clin Endocrinol Metab 1998;83:969-75.
21. Schmitt JF, Millar DS, Pedersen JS, et al. Hypermethylation of the inhibin α-subunit gene in prostate carcinoma. Mol Endocrinol 2002;16:213-20.
22. Risbridger GP, Ball EM, Wang H, Mellor SL, Peehl DM. Re-evaluation of inhibin a subunit as a tumour suppressor in prostate cancer. Mol Cell Endocrinol 2004;225:73-6.
23. Meehan T, Schlatt S, O'Bryan MK, de Kretser DM, Loveland KL. Regulation of germ cell and Sertoli cell development by activin, follistatin, and FSH. Dev Biol 2000;220:225-37.
24. Loveland KL, Hogarth C, Mendis S, et al. Drivers of germ cell maturation. Ann N Y Acad Sci 2005;1061:173-82.
25. van Schaik RH, Wierikx CD, Looijenga LH, Oosterhuis JW, de Jong FH. Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs. Br J Cancer 1997;76:1191-8.
26. Cobellis L, Cataldi P, Reis FM, et al. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits. Eur J Endocrinol 2001;145:779-84.
27. Hansen PV, Trykker H, Andersen J, Helkjaer PE. Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989;64:956-61.
28. Wanderas EH, Fossa SD, Heilo A, Stenwig AE, Norman N. Serum follicle stimulating hormone-predictor of cancer in the remaining testis in patients with unilateral testicular cancer. Br J Urol 1990;66:315-7.
29. Nylander PP. Serum levels of gonadotrophins in relation to multiple pregnancy in Nigeria. J Obstet Gynaecol Br Commonw 1973;80:651-3.
30. Nylander PP. The factors that influence twinning rates. Acta Genet Med Gemellol 1981;30:189-202.
31. Martin NG, El Beaini JL, Olsen ME, Bhatnagar AS, Macourt D. Gonadotropin levels in mothers who have had two sets of DZ twins. Acta Genet Med Gemellol 1984;33:131-9.
32. Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 1995;6:519-24.
33. Swerdlow AJ, De Stavola BL, Swanwick MA, Maconochie NE. Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 1997;350:1723-8.
34. Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer 1997;80:929-35.
35. Sicinski P, Donaher JL, Geng Y, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996;384:470-4.
36. Kumar TR, Palapattu G, Wang P, et al. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 1999;13:851-65.